Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA plans to phase out animal testing requirement for monoclonal antibodies, other drugs

Ruchika Sharma11 April 2025 4:08 PM IST

In a significant move toward modernizing drug development, the U.S. Food and Drug Administration (USFDA) has announced plans to phase out its...

Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals

Granules India successfully closes acquisition of Swiss based CDMO Senn Chemicals

Ruchika Sharma11 April 2025 3:05 PM IST

Hyderabad: Granules India Limited has announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss based Contract...

Teva Pharma announces USFDA filing acceptance for Ajovy in Pediatric Episodic Migraine prevention

Biocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult patients

Ruchika Sharma11 April 2025 12:30 PM IST

Bangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval...

Cipla Bommasandra facility gets VAI classification from USFDA

Cipla gets USFDA nod for Paclitaxel Protein bound Particles for Injectable Suspension

Ruchika Sharma11 April 2025 11:30 AM IST

Mumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the ...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

JnJ gets European Commission nod for subcutaneous Darzalex-based quadruplet regimen for newly diagnosed multiple myeloma

Ruchika Sharma11 April 2025 10:30 AM IST

Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has received approval from the European Commission (EC) for an...

Sanofi India Rodolfo Hrosz resigns as MD

Ruchika Sharma10 April 2025 4:11 PM IST

Mumbai: Sanofi India has announced that Rodolfo Hrosz, Managing Director of the Company, will step down from his current role effective April 30,...

Granules recalls over 33000 bottles BP medication in US

Biocon, Glenmark recall anxiety, high cholesterol medications in US

Ruchika Sharma10 April 2025 3:17 PM IST

Biocon and Glenmark are recalling anxiety and high cholesterol medications from US market due to manufacturing concerns, according to the U.S. Food...

Zydus Lifesciences bags USFDA okay for arthritis drug Celecoxib

Shilpa Medicare bags USFDA approval for Varenicline Tablets for smoking cessation

Ruchika Sharma10 April 2025 1:17 PM IST

Karnataka: Shilpa Medicare Limited has received approval from the US Food and Drugs Administration (USFDA) for Varenicline Tablets, 0.5 and 1...

Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer

Biocon Biologics gets USFDA nod for cancer drug Jobevne

Ruchika Sharma10 April 2025 12:39 PM IST

Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration (U.S. FDA) has...

Aurobindo Pharma restarts production at Kakinada Penicillin-G plant after fire incident

Aurobindo Pharma arm CuraTeQ Biologics completes successful Phase 1 Pharmacokinetics study of bone drug

Ruchika Sharma10 April 2025 11:56 AM IST

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the cells that break down bone.

Shaik Barak Tulla joins Sun Pharma as Senior Vice President and Head of Acute Clusters

Ruchika Sharma9 April 2025 7:04 PM IST

Sun Pharma has appointed Shaik Barak Tulla as the new Senior Vice President and Head of Acute Clusters. The industry veteran brings with him over 25...

Parliamentary Panel warns of antibiotic overuse, calls for AMR curriculum overhaul

Ruchika Sharma9 April 2025 6:30 PM IST

Taking cognisance of the overuse of antibiotics leading to Anti-microbial resistance in people, a Parliamentary Health Committee has recommended...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok